Search Materials

This fact sheet provides information on the global burden of TB, TB targets, and the new Stop TB Strategy.

This is an achievement report about the Global Drug Facility (GDF), a key initiative of the STOP TB Partnership, which has had a positive impact on the treatment of millions of TB patients globally since its establishment in 2001. By providing high-quality TB drugs to over 4.4 million people in some of the world's poorest countries, it has helped to save lives and has significantly strengthened global TB control efforts.

Treatment Action Group (TAG) analyzes and reports on the annual funding of tuberculosis (TB ) research and development (R&D). The top 40 TB research funding institutions were surveyed for actual disbursements made for TB R&D in fiscal years 2005, 2006, and now 2007. The three-year data reveal trends in funding and demonstrates an alarming shortfall in the growth of TB R&D during the initial years covered by The Global Plan to Stop TB: 2006–2015.

The primary purposes of this framework are to: 1) promote, enhance, and intensify TB research and innovation at the country level, and 2) promote, enhance, and catalyze TB research at the global level through advocacy, innovation, discussion of global priorities, and the development of networks for research and capacity building.

This pocket guide provides information on the phases of partnership building.

This report details the activities of the International Union Against Tuberculosis and Lung Disease (The Union) for the year 2008.

This document provides general guidance and examples on implementing contact investigations in low- and middle-income settings. The World Health Organization (WHO) policy document "Recommendations for Inves­tigating Contacts of Persons with Infectious Tuberculosis in Low- and Middle-Income Countries", published in late 2012, presents definitions and recommendations for what should be done for contact investigation; this doc­ument presents suggestions and examples of how the recommendations can be put into operation.

The purpose of this document is to highlight cases in which Advocacy, Communication and Social Mobilization (ACSM) interventions have contributed to a positive outcome of tuberculosis (TB) control activities directed to a range of audiences and settings. It is intended for on-the-ground stakeholders who are interested in successfully integrating ACSM strategies and activities into TB control programming, as well as for decision-makers who can provide greater political and financial support for ACSM activities at the national, sub-national and international level.